Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results
Completed enrollment of the pivotal STRIDE study; topline results anticipated 4Q 2023Raised $68.3 million in gross proceeds from a concurrent public offering and private placement IRVINE, Calif.,... | May 11, 2023
Source: marketscreener.com
